Disparities in GBM treatment: Demand More!
Survey shows huge disparities in treatment.
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
White House Cancer Moonshot
OurBrainBank is proud that the White House invited us to be part of the ambitious Cancer Moonshot effort. Read the latest from Washington DC.
OurBrainBank at SNO — Society for Neuro-Oncology — Annual Conference
Executive Director Kelli Duprey presented our poster about treatment disparities at SNO 2023
Clinical trial for people newly diagnosed with glioblastoma
Clinical trial for people newly diagnosed with glioblastoma
Stanford Researchers look to Artificial Intelligence to help plan GBM treatment
Model could help doctors identify patients with cellular characteristics that indicate more aggressive tumors, and flag them for accelerated follow-up.
Books about brain tumors and glioblastoma
Reading books about glioblastoma and other brain tumors can help.
Guide to sponsored patient support programs from pharma and device companies
Each year, Oncology Practice Management updates this comprehensive guide to sponsored patient support programs.
Running the Brighton Marathon to benefit OurBrainBank UK
Founder Jessica Morris’s family is running the Brighton marathon to raise funds for OurBrainBank!
OurBrainBank at SNO Annual Meeting 2024
This week, we presented preliminary results of our ambitious survey of 500+ people affected by GBM at the Society for Neuro-Oncology annual conference.
OurBrainBank benefit event in Connecticut Nov. 22, 2024
A good time was had by all at a festive evening of fun, live music, great food and drinks — all to benefit OurBrainBank. Let us know if you’d like to host a benefit event for us.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
